secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001193125-25-037533
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance appoints Dave Bourdon as CEO; Ken Burdick becomes Executive Chairman; Ryan McGroarty named CFO
--------------------------------------------------------------------------------

- Dave Bourdon, CFO since 2022, becomes CEO effective March 3, 2025; Ryan McGroarty appointed CFO effective March 17, 2025.
- Ken Burdick retires as CEO and becomes Executive Chairman, continuing on the Board.
- Bourdon's new annual base salary is $700,000; target bonus 100% of salary for 2025.
- McGroarty receives $550,000 base salary, $570,000 signing bonus, and $5M target equity award (RSUs and PSUs).
- Both appointments follow nine consecutive quarters of meeting or exceeding financial expectations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/d911509d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-037533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer